Estrogen* |
Oral | Conjugated estrogens (Premarin) | 0.3, 0.45, 0.625, 0.9, 1.25 |
Transdermal | 17β-estradiol (Estrace) | 0.5, 1.0, 2.0 |
17β-estradiol (Alora) | 0.025, 0.05, 0.075, 0.1 (patch applied twice weekly) |
17β-estradiol (Climara) | 0.025, 0.0375, 0.05, 0.075, 0.1 (patch applied weekly) |
Vaginal | Estradiol acetate (Femring vaginal insert†) | 0.05, 0.1 (inserted every 90 days) |
Progestogen |
Oral | MPA (Provera) | 2.5, 5.0, 10.0 |
Micronized progesterone (Prometrium) | 100, 200 (in peanut oil) |
Vaginal | Progesterone (Prochieve 4%) | 45 |
Combined preparation |
Oral sequential‡ | Conjugated estrogens and MPA (Premphase) | 0.625 conjugated estrogens plus 5.0 MPA |
Oral continuous§ | Conjugated estrogens and MPA (Prempro) | 0.625 conjugated estrogens plus 2.5 or 5.0 MPA; |
or |
0.45 conjugated estrogens plus 2.5 MPA; |
or |
0.3 or 0.45 conjugated estrogens plus 1.5 MPA |
Transdermal continuous§ | 17β-estradiol–norethindrone acetate (Activella) | 1.0 estradiol plus 0.5 norethindrone |
17β-estradiol–levonorgestrel (Climara Pro) | 0.045 estradiol plus 0.015 levonorgestrel (patch applied weekly) |
17β-estradiol–norethindrone acetate (Combipatch) | 0.05 estradiol plus 0.14 or 0.25 norethindrone (patch applied twice weekly) |